ETEL RODRIGUES PEREIRA GIMBA

Scopus Publications

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib
Gabriela Ribeiro Silva, Amanda Lewis Rubim, Flavia da Cunha Vasconcelos, Luciana Bueno Ferreira, John Greenman, et al.
Biomedicines, 2026
Background/Objectives: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal forms of malignant neoplasm of the endocrine system, and osteopontin (OPN) has been shown to be aberrantly expressed in this tumor type. Among the five OPN splicing isoforms (OPN-SI), OPN-4 has been recently reported in several tumor types, including ATC, but its functional role(s) have not yet been elucidated. Methods: To characterize OPN-4 roles in ATC cells, OPN-4 was ectopically overexpressed in the c643 ATC cell line, generating the c643/OPN-4 cells. OPN-roles were evaluated by cell functional assays, including cell proliferation and viability, using Carboxyfluorescein Succinimidyl Ester (CFSE), crystal violet, and trypan blue assays. For migration, clonogenicity, cell cycle and apoptosis assays were used. For assessment, c643/OPN-4 cells were cultured in two-dimensional (2D) monolayers or three-dimensional (3D) spheroids with the latter being maintained in a bespoke microfluidic system. Results: OPN-4 overexpression led to a significant reduction in cell proliferation, viability, migration and clonogenicity. c643/OPN-4 cells displayed a significant accumulation in the G0/G1 phase and a decrease in the S phase of the cell cycle; however this did not affect cell death or the expression levels of other OPN-SI. In a spheroid model of c643/OPN-4 cells, no significant differences were found in spheroid size or viability when compared to those formed by control cells. Notably, OPN-4 overexpression enhanced the effects of sorafenib on cell viability under dynamic treatment conditions involving continuous perfusion. Conclusions: These early findings point to the fact that OPN-4 may reduce some aspects of tumor progression features in ATC cells and open new avenues for investigating OPN-4 as a biomarker of therapeutic response in personalized treatment strategies.
Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses
Mariana Concentino Menezes Brum, Annie Cristhine Moraes Sousa Squiavinato, Luciana da Torre Carneiro, Luciana Bueno Ferreira, Alessandra Serain, et al.
Tumor Biology, 2025
Background Osteopontin is a glycophosphoprotein aberrantly expressed in several tumor types, which exhibits several isoforms generated by post-translational and post-transcriptional mechanisms, including alternative splicing. Among total osteopontin (tOPN), the osteopontin-c (OPN-c) splice variant has been the most explored with an oncogenic role described for a range of tumor types. Especially in ovarian cancer (OC) cells, OPN-c is found overexpressed, presenting both diagnostic and prognostic implications. Objective In this review article, we aim to outline OPN-c roles in cancer, particularly in OC, in which it has been reported as a diagnostic biomarker. Methods We used PubMed search, and experimental procedures were summarized at the Figure legends. Results We identified cytoplasmic, perinuclear, and nuclear OPN-c in OC cells that overexpress this OPN splice variant. Moreover, we report that OPN-c splicing isoform is found highly expressed in endometrioid OC patients’ samples, compared to non-neoplastic ovarian tissues. Also, OPN-c expression levels have been associated with worse overall survival and worse progression-free survival in patients with both endometrioid and serous OC. Furthermore, OPN-c may be involved in a wide range of tumor features evoked by signaling pathways, such as AKT, ERK, and FAK. Conclusions Therefore, a better comprehension of OPN-c roles in OC can further contribute to its application as a biomarker as well as a target for putative treatment strategies, especially those aiming to sensitize tumor cells to chemotherapeutic agents currently used in the OC treatment.
IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line
Amanda de Albuquerque, Bruno A. Lopes, Renan Amphilophio Fernandes, Etel Rodrigues Pereira Gimba, Mariana Emerenciano
Hematology Transfusion and Cell Therapy, 2024
Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
Daniella Mattos, Murilo Rocha, Josiane Tessmann, Luciana Ferreira, Etel Gimba
Diagnostics, 2024
Background: Osteopontin (OPN) is a glycoprotein involved in various physiological and pathological processes, and its aberrant expression in cancer cells is closely linked to tumor progression. In colorectal cancer (CRC), OPN is overexpressed, but the roles of its splice variants (OPN-SVs), OPNa, OPNb, and OPNc, are not well understood. This study aimed to characterize the expression patterns of OPN-SVs and their potential diagnostic and prognostic implications in CRC using transcriptomic data deposited in TSVdb and TCGA. Methods: The expression patterns of each OPN-SV were analyzed using transcriptomic data deposited in TSVdb and TCGA, which were correlated to patient data available at cBioPortal. Results: Bioinformatic analysis revealed that OPNa, OPNb, and OPNc are overexpressed in CRC samples compared to non-tumor samples. Notably, OPNa and OPNc are overexpressed in CRC stages (II, III, and IV) compared to stage I. Higher levels of OPNa and OPNc transcripts are associated with worse overall survival (OS) and shorter progression-free survival (PFS) in CRC patients. Additionally, the expression of OPNa, OPNb, and OPNc is correlated with BRAFV600E mutations in CRC samples. Conclusions: These findings suggest that OPNa and OPNc, in particular, have potential as diagnostic and prognostic biomarkers, paving the way for their further evaluation in CRC diagnosis and prognosis.
Expression and prognostic potential of osteopontin splice variants in malignant melanoma
Gabriela Ribeiro Silva, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Clinical and Translational Science, 2024
Total Osteopontin and Its Isoform OPN4 Are Differently Expressed in Respiratory Samples during Influenza A(H1N1)pdm09 Infection and Progression
Jéssica Santa Cruz de Carvalho Martins, Thiago das Chagas Sousa, Maria de Lourdes de Aguiar Oliveira, Etel Rodrigues Pereira Gimba, Marilda Mendonça Siqueira, et al.
Microorganisms, 2023
Influenza A virus (IAV) infection affects the human respiratory tract, causing an acute and highly contagious disease. Individuals with comorbidities and in the extremes of age are classified as risk groups for serious clinical outcomes. However, part of the severe infections and fatalities are observed among young healthy individuals. Noteworthy, influenza infections lack specific prognostic biomarkers that would predict the disease severity. Osteopontin (OPN) has been proposed as a biomarker in a few human malignancies and its differential modulation has been observed during viral infections. However, OPN expression levels in the primary site of IAV infection have not been previously investigated. Therefore, we evaluated the transcriptional expression patterns of total OPN (tOPN) and its splicing isoforms (OPNa, OPNb, OPNc, OPN4, and OPN5) in 176 respiratory secretion samples collected from human influenza A(H1N1)pdm09 cases and a group of 65 IAV-negative controls. IAV samples were differentially classified according to their disease severity. tOPN was more frequently detected in IAV samples (34.1%) when compared with the negative controls (18.5%) (p < 0.05), as well as in fatal (59.1%) versus non-fatal IAV samples (30.5%) (p < 0.01). OPN4 splice variant transcript was more prevalent in IAV cases (78.4%) than in the negative controls (66.1%) (p = 0.05) and in severe cases (85.7%) in relation to the non-severe ones (69.2%) (p < 0.01). OPN4 detection was also associated with severity symptoms such as dyspnea (p < 0.05), respiratory failure (p < 0.05), and oxygen saturation < 95% (p < 0.05). In addition, the OPN4 expression level was increased in the fatal cases of respiratory samples. Our data indicated that tOPN and OPN4 had a more pronounced expression pattern in IAV respiratory samples, pointing to the potential use of these molecules as biomarkers to evaluate disease outcomes.
Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia
Elda Pereira Noronha, Priscilla Moniz Sodré Ferreira, Francianne Gomes Andrade, Caroline Barbieri Blunck, Ricardo Camargo, et al.
Hematology Transfusion and Cell Therapy, 2023
The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles
Ana Clara Santos da Fonseca Bastos, Amanda Vitória Pampolha Gomes, Gabriela Ribeiro Silva, Mariana Emerenciano, Luciana Bueno Ferreira, et al.
International Journal of Molecular Sciences, 2023
Classically, osteopontin (OPN) has been described as a secreted glycophosprotein. Indeed, most data concerning its physiological and pathological roles are mainly related to the secreted OPN (sOPN). However, there are several instances in which intracellular OPN (iOPN) has been described, presenting some specific roles in distinct experimental models, such as in the immune system, cancer cells, and neurological disorders. We herein aimed to highlight and discuss some of these secreted and intracellular roles of OPN and their putative clinical and biological impacts. Moreover, by consolidating data from the OPN protein database, we also analyzed the occurrence of signal peptide (SP) sequences and putative subcellular localization, especially concerning currently known OPN splicing variants (OPN-SV). Comprehending the roles of OPN in its distinct cellular and tissue environments may provide data regarding the additional applications of this protein as biomarkers and targets for therapeutic purposes, besides further describing its pleiotropic roles.
Bovine Lactoferrin Induces Cell Death in Human Prostate Cancer Cells
Vanessa P. Rocha, Samir P. C. Campos, Caroline A. Barros, Pablo Trindade, Leticia R. Q. Souza, et al.
Oxidative Medicine and Cellular Longevity, 2022
Bovine lactoferrin (bLf) is a multifunctional protein widely associated with anticancer activity. Prostate cancer is the second most frequent type of cancer worldwide. This study was aimed at evaluating the influence of bLf on cell viability, cell cycle progression, reactive oxygen species (ROS) production, and rate of apoptosis in the human prostate cancer cell line (DU‐145). MTT assay and trypan blue exclusion were used to analyze cell viability. Morphological changes were analyzed through optical microscopy after 24 h and 48 h of bLf treatment. FITC‐bLf internalization and cellular damage were observed within 24 h by confocal fluorescence microscopy. Cell cycle analyses were performed by flow cytometry and propidium iodide. For caspases 3/7 activation and reactive oxygen species production evaluation, cells were live‐imaged using the high‐throughput system Operetta. The cell viability assays demonstrated that bLf induces cell death and morphological changes after 24 h and 48 h of treatment compared to control on DU‐145 cells. The bLf internalization was detected in DU‐145 cells, G1‐phase arrest of the cell cycle, caspase 3/7 activation, and increased oxidative stress on bLf‐treated cells. Our data support that bLf has an important anticancer activity, thus offering new perspectives in preventing and treating prostate cancer.
LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
Isabel J. Dionísio de Sousa, Ana Isabel Cunha, Inês A. Saraiva, Raquel V. Portugal, Etel R.P. Gimba, et al.
Pathobiology, 2021
Background: Pegylated liposomal doxorubicin (PLD) is among the most active therapies for recurrent/progressive ovarian cancer (OC). Low-density lipoprotein receptor-related protein 1B (LRP1B) is one of the 10 most significantly deleted genes in human cancers. It mediates endocytosis of several factors from the cellular environment including liposomes. Although the LRP1B role in cancer has not been fully disclosed, its contribution to resistance to liposomal therapies has been hypothesized. This study aimed to evaluate the impact of LRP1B protein as a possible marker of response to PLD in patients with OC. Methods: LRP1B expression and response to PLD were analyzed in OC cell lines by qRT-PCR and PrestoBlue viability assay, respectively. LRP1B protein expression was evaluated for the first time, in tumor samples from PLD-treated patients and controls (other chemotherapies) by immunohistochemistry. Association of LRP1B staining score (determined based on intensity and percentage of positively stained cells) with clinicopathological features, response to therapy and survival outcomes was evaluated. Results: OC cells with increased expression of LRP1B were more sensitive to PLD. LRP1B staining score was associated with clinicopathological features, response to therapy, and survival outcomes. Higher LRP1B levels were associated with prolonged progression-free survival. This association was more evident in patients treated with PLD and in responders to PLD. Conclusion: Our results support a possible role of LRP1B as a predictor of response to PLD in patients with OC.
Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities
Ana Emília Goulart Lemos, Gabriela Ribeiro Silva, Etel Rodrigues Pereira Gimba, Aline da Rocha Matos
Thoracic Cancer, 2021
Osteopontin expression in thyroid cancer: Deciphering emt‐ related molecular mechanisms
Bruna Prunes Pena Baroni Viana, Amanda Vitória Pampolha Gomes, Etel Rodrigues Pereira Gimba, Luciana Bueno Ferreira
Biomedicines, 2021
(3,3’-Methylene)bis-2-hydroxy-1,4-naphthoquinones induce cytotoxicity against DU145 and PC3 cancer cells by inhibiting cell viability and promoting cell cycle arrest
Paula Priscilla de Freitas, Ruan Carlos Busquet Ribeiro, Isabella dos Santos Guimarães, Caroline S. Moreira, David R. Rocha, et al.
Molecular Biology Reports, 2021
Osteopontin-c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity
Mariana Concentino Brum, Isabella Dos Santos Guimaraes, Luciana Ferreira, Leticia Batista Rangel, Raquel Maia, et al.
Oncology Reports, 2021
Bioactive compounds, antioxidant activity and antiproliferative effects in prostate cancer cells of green and roasted coffee extracts obtained by microwave-assisted extraction (MAE)
Júlia Montenegro, Lauriza Silva dos Santos, Rodrigo Gonçalves Gusmão de Souza, Larissa Gabrielly Barbosa Lima, Daniella Santos Mattos, et al.
Food Research International, 2021
Molecular aspects of thyroid calcification
Luciana Bueno Ferreira, Etel Gimba, João Vinagre, Manuel Sobrinho-Simões, Paula Soares
International Journal of Molecular Sciences, 2020
Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines
Gabriela Ribeiro Silva, Daniella Santos Mattos, Ana Clara Fonseca Bastos, Bruna Prunes Pena Baroni Viana, Mariana Concentino Menezes Brum, et al.
Molecular Biology Reports, 2020
Predictive biomarkers and patient outcome in platinum-resistant (PLD-treated) ovarian cancer
Isabel J. Dionísio de Sousa, Durval S. Marques, Catarina Príncipe, Raquel V. Portugal, Sule Canberk, et al.
Diagnostics, 2020
Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1”
Ana Clara Santos da Fonseca Bastos, Abigail Cristina da Silva Rezende, Luciana Bueno Ferreira, Caroline Barbieri Blunck, Maria S. Pombo-de-Oliveira, et al.
Leukemia Research, 2020
A new strategy for the synthesis of nonsymmetrical 3,3’-(aryl/alkyl-methylene) bis-2-hydroxy-1,4-naphthoquinones and their cytotoxic effects in PC3 prostate cancer cells
Ruan Carlos Ribeiro, Paula de Freitas, Caroline Moreira, Leonardo de Moraes, Matheus de Moraes, et al.
Journal of the Brazilian Chemical Society, 2020
Amazon fruits inhibit growth and promote pro-apoptotic effects on human ovarian carcinoma cell lines
Vanessa Rosse de Souza, Mariana Concentino Menezes Brum, Isabella dos Santos Guimarães, Paula de Freitas dos Santos, Thuane Oliveira do Amaral, et al.
Biomolecules, 2019
The LQB-223 compound modulates antiapoptotic proteins and impairs breast cancer cell growth and migration
Lauana Greicy Tonon Lemos, Gabriel Mello da Cunha Longo, Bruna dos Santos Mendonça, Marcela Cristina Robaina, Mariana Concentino Menezes Brum, et al.
International Journal of Molecular Sciences, 2019
Loss of the p53 transactivation domain results in high amyloid aggregation of the δ40p53 isoform in endometrial carcinoma cells
Nataly Melo dos Santos, Guilherme A.P. de Oliveira, Murilo Ramos Rocha, Murilo M. Pedrote, Giulia Diniz da Silva Ferretti, et al.
Journal of Biological Chemistry, 2019
Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review)
Etel Gimba, Mariana Brum, Gabriela Nestal De Moraes
International Journal of Oncology, 2019
The long non-coding RNA PCA3: An update of its functions and clinical applications as a biomarker in prostate cancer
Ana Emília Goulart Lemos, Aline da Rocha Matos, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Oncotarget, 2019
Reinforcing osteopontin as a marker of central nervous system relapse in paediatric B-cell acute lymphoblastic leukaemia: SPP1 splice variant 3 in the spotlight
Júlio C. Santoro, Ana C. S. F. Bastos, Etel R. P. Gimba, Mariana Emerenciano
British Journal of Haematology, 2019
OPNa overexpression is associated with matrix calcification in thyroid cancer cell lines
Luciana B. Ferreira, Raquel T. Lima, Ana Clara Santos da Fonseca Bastos, Andreia M. Silva, Catarina Tavares, et al.
International Journal of Molecular Sciences, 2018
Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines
Isabella dos Santos Guimarães, Taciane Ladislau-Magescky, Nayara Gusmão Tessarollo, Diandra Zipinotti dos Santos, Etel Rodrigues Pereira Gimba, et al.
Pharmacological Reports, 2018
Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues
Ana Clara Santos Fonseca Bastos, Caroline Barbieri Blunck, Mariana Emerenciano, Etel Rodrigues Pereira Gimba
Cancer Letters, 2017
Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines
Durval Santos Marques, Jessica Grativol, Rodrigo Alves da Silva Peres, Aline da Rocha Matos, Etel Rodrigues Pereira Gimba
Tumor Biology, 2017
Lycopene extracts from different tomato-based food products induce apoptosis in cultured human primary prostate cancer cells and regulate TP53, Bax and Bcl-2 transcript expression
Asian Pacific Journal of Cancer Prevention, 2017
PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells
Ana Emília Goulart Lemos, Luciana Bueno Ferreira, Nadia Maria Batoreu, Paula Priscilla de Freitas, Martin Hernan Bonamino, et al.
Tumor Biology, 2016
Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
Luciana Bueno Ferreira, Catarina Tavares, Ana Pestana, Catarina Leite Pereira, Catarina Eloy, et al.
Oncotarget, 2016
Aberrant levels of Wnt/β-catenin pathway components in a rat model of endometriosis
Histology and Histopathology, 2016
Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
Luciana Bueno Ferreira, Catarina Eloy, Ana Pestana, Joana Lyra, Margarida Moura, et al.
European Journal of Endocrinology, 2016
Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells
K. D. M. Nakamura, T. M. Tilli, J. L. Wanderley, A. Palumbo, R. M. Mattos, et al.
Tumor Biology, 2016
Osteopontin-C mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling
TATIANA MARTINS TILLI, LUCIANA BUENO FERREIRA, ETEL RODRIGUES PEREIRA GIMBA
Oncology Letters, 2015
Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines
Tatiana M Tilli, Akeila Bellahcène, Vincent Castronovo, Etel R P Gimba
BMC Cancer, 2014
Lycopene induce apoptosis in human prostate cells and alters the expression of Bax and Bcl-2 genes
Nathalia da Costa Pereira Soares, Anderson Junger Teodoro, Felipe Leite Oliveira, Christina Maeda Takiya, Antonio Palumbo Junior, et al.
Lwt, 2014
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: Emerging functional associations
Angela A Fachel, Ana C Tahira, Santiago A Vilella-Arias, Vinicius Maracaja-Coutinho, Etel RP Gimba, et al.
Molecular Cancer, 2013
Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells
Nathalia da Costa Pereira Soares, Anderson Junger Teodoro, Felipe Leite Oliveira, Carlos Antonio do Nascimento Santos, Christina Maeda Takiya, et al.
Nutrition and Cancer, 2013
Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia
A.R. Matos, C.M. Coutinho-Camillo, L.C.S. Thuler, F.P. Fonseca, F.A. Soares, et al.
Experimental and Molecular Pathology, 2013
Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways
E.R. Gimba, T.M. Tilli
Cancer Letters, 2013
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
Luciana Bueno Ferreira, Antonio Palumbo, Kivvi Duarte de Mello, Cinthya Sternberg, Mauricio S Caetano, et al.
BMC Cancer, 2012
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells
Tatiana M. Tilli, Kivvi D. Mello, Luciana B. Ferreira, Aline R. Matos, Maria Thereza S. Accioly, et al.
Prostate, 2012
Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells
Antonio Palumbo, Luciana Bueno Ferreira, Pedro A.V. Reis de Souza, Felipe Leite de Oliveira, Bruno Pontes, et al.
Cancer Letters, 2012
Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia
T.M. Tilli, L.C. Thuler, A.R. Matos, C.M. Coutinho-Camillo, F.A. Soares, et al.
Experimental and Molecular Pathology, 2012
Osteopontin-c splicing isoform contributes to ovarian cancer progression
Tatiana M. Tilli, Vanessa Ferreira Franco, Bruno Kaufmann Robbs, João Luiz Mendes Wanderley, Fabrício Ribeiro de Azevedo da Silva, et al.
Molecular Cancer Research, 2011
Osteopontin is a tumor autoantigen in prostate cancer patients
TATIANA M. TILLI, ELOÍSIO A. SILVA, LÍVIA C. MATOS, DOUGLAS V. FAGET, BIANCA F.P. DIAS, et al.
Oncology Letters, 2011
Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma
Glauber Costa Brito, Ângela A. Fachel, Andre Luiz Vettore, Giselle M Vignal, Etel R.P. Gimba, et al.
Molecular Carcinogenesis, 2008
Auto-antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3
E.R. Pontes, L.C. Matos, E.A. da Silva, L.S. Xavier, B.L. Diaz, et al.
Prostate, 2006
Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma
I.M. Guerrero, C.H.C. Pessoa, D.B. Olmedo, E.R.P. Pontes, L.C. Matos, et al.
Thyroid, 2006
Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer
Eduardo M Reis, Helder I Nakaya, Rodrigo Louro, Flavio C Canavez, Áurea V F Flatschart, et al.
Oncogene, 2004
Molecular aspects of prostate cancer: Implications for future directions
Etel R. P. Gimba, Marcello A. Barcinski
International Braz J Urol, 2003
Lack of DNA methylation in Schistosoma mansoni
Marcelo Rosado Fantappié, Etel Rodrigues Pereira Gimba, Franklin David Rumjanek
Experimental Parasitology, 2001
Cloning and characterization of Echinococcus granulosus (Cestode) EgactI and EgactII actin gene promoters and their functional analysis in the NIH3T3 mouse cell line
E.R.P. Gimba, G. Chemale, S.S. Farias, A. Zaha
Brazilian Journal of Medical and Biological Research, 2000

ETEL RODRIGUES PEREIRA GIMBA

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications